Drug Manufacturers Face Public Opinion Challenge In Medicare Rx
Pharmaceutical manufacturers face a significant challenge in countering bad publicity about the Medicare prescription drug program, National Pharmaceutical Council President Karen Williams said at a World Congress Leadership Summit on Medicare May 23 in Washington, D.C
You may also be interested in...
Medicare beneficiaries in the discount card program are demonstrating little loyalty to particular pharmacies, Medco Senior VP-Medical Affairs Robert Epstein said
The catastrophic coverage provided under the Medicare Part D benefit may give private plan sponsors little incentive to control use of high-cost drugs, American Enterprise Institute Resident Fellow Scott Gottlieb said April 27
Pharmacists will have to keep careful track of prescriptions for some medicines that can be covered by Medicare Part B once the new Part D outpatient drug benefit begins in 2006